J&J's Cordis wins heart stent patent appeal
123618
Cordis Corp, a unit of Johnson & Johnson , won the latest round on Monday in a patent fight with Medtronic Inc  and Boston Scientific Corp  over who owns lucrative patents for heart stents.
244877
A US appeal court has delivered a mixed ruling in a patent dispute between Research in Motion (RIM) and NTP. It upholding a decision that RIM had infringed on patents held by NTP, but cancelled an injunction
110146
Johnson & Johnson said Thursday that its Cordis unit has resolved its issues with the F.D.A., clearing the way for the introduction of new cardiovascular devices.
243896
Boston Scientific Corp. has reserved another $101 million to defend itself against lawsuits over defibrillators made by Guidant Corp., the heart-device maker it acquired for $27 billion last year. The Natick medical-device company has set aside $485 million to pay for legal costs related to Guidant, it said in a filing this week, up from $384 million in ...
587392
Boston Scientific Corp., the world&#39;s largest maker of heart stents, said US sales of its top-selling Taxus device recovered in August after three recalls led some doctors to stop using the product.
301149
Cambridge Antibody Technology&#39;s (Nasdaq: CATG) legal victory over Abbott Laboratories (NYSE: ABT) shows that a biotech David can triumph over a pharmaceutical Goliath.
58780
Canada's Angiotech Pharmaceuticals Inc.  said on Monday that European regulators upheld a patent related to its drug-coated coronary stents.
223573
Health-care products maker Johnson & Johnson  won U.S. approval to sell a new HIV drug called Intelence for patients with resistance to other therapies, U.S. officials said on Friday.
645703
NEW YORK -- Results of a Korean study released yesterday show Cordis Corp.'s Cypher drug-coated stent outperformed Boston Scientific Corp.'s Taxus Express2 stent in a multicenter study.
244890
A U.S. judge on Tuesday ruled that the  patent on the multibillion-dollar blood clot-preventing drug  Plavix is valid, handing a major victory to Bristol-Myers  Squibb Co.  and Sanofi-Aventis .
717588
Indianapolis-based Guidant Corp., which co-promotes Johnson &amp; Johnson&#39;s Cypher drug-coated heart stent, says the device&#39;s market share has risen by as much as half, helped by Boston Scientific Corp.
65024
Johnson &amp; Johnson's neck stent is as effective as surgery in clearing blocked blood vessels to the brain that can cause strokes and death, according to a company-funded study in tomorrow's New England Journal of Medicine.
425924
A federal judge on Tuesday ruled that the patent on the blood clot-preventing drug Plavix is valid, handing a major victory to Bristol-Myers Squibb and Sanofi-Aventis.
519920
Boston Scientific Corp. , of Natick, is seeking to market its Taxus heart stent to diabetics in the United States, who make up one-third of all stent patients. Taxus shows signs of being at least as effective and safe in diabetics as the rival Cypher stent, made by Johnson &amp; Johnson, Donald Baim, chief scientific officer at Boston ...
293991
BlackBerry maker Research In Motion  (RIM)   won a second victory in a key UK patent  lawsuit on Wednesday that had threatened the future of  BlackBerry's e-mail service in Britain.
718979
The Supreme Court handed a victory  to Medtronic Inc  on Wednesday, ruling that patients  cannot sue medical-device manufacturers in state court over  harm from a device that has approval from federal regulators.
155100
Standard &amp; Poor's raised its outlook on Boston Scientific Corp. to positive from stable, citing its recovery of market share for its drug-coated Taxus cardiac stent after recalls that began in July. The debt rating agency said the upgrade reflects the Natick company's &quot;surprisingly rapid recovery&quot; of market share for Taxus, and its diverse product line. Last week, Boston Scientific ...